TrumpRx, Affirmative Action Fallout, American Dominance Ending?

Mike and Ken open this supporters’ exclusive midweek episode with a look at TrumpRx, a government-branded prescription drug discount portal. Mike points out that it offers real savings on certain high-cost drugs and signals a willingness to confront pharmaceutical pricing, but suggests it may function more as a Big Pharma marketing funnel than structural reform. Ken contends it risks undermining insurance markets, misdirects consumers from systemic solutions like negotiation or single-payer leverage, and may create perverse incentives while doing little beyond what private platforms already offer.

Next, the guys turn to new post–SFFA admissions data showing decl...